WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :

Download Article: Click Here

Search

Track Your Article

Abstract

STUDIES OF PRODRUG APPROACH IN ANTICANCER DRUGS

Rutuja Bhumkar* and Anuruddha Rajaram Chabukswar

Abstract

A prodrug is pharmacologically inactive, meaning it needs to be converted into an active drug by enzyme or chemical processes that are metabolized in the body that are designed to increase the amount of active drug at the site of action. Prodrugs in anticancer treatment can help to reduce side effects and limitations of conventional anticancer treatment because conventional drugs have high systemic toxicity and lack tumor selectivity. Natural products can also address cancer, but because of systemic toxicity or lack of tumor selectivity, a prodrug strategy will help in overcoming these limitations. To get a more effective outcome in cancer therapy, try combining nanoparticles or photouncaging methods with a prodrug. Human carcinogenesis is caused by CYP1A1, therefore inhibition of its activity may result in chemoprevention. Lipophilic prodrugs combined with nanotechnology can be used to design liposomes that overcome drawbacks. We will provide a summary of recent research article reports on anticancer prodrugs.

Keywords: Anticancer drug, Amphiphilic nano theranostic, Curcumin, Camptothecin, Emetine, Gene-directed enzyme prodrug therapy.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More